AZIRIDINIUM-PERCHLORATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2nRGYu6IIbC |
|---|---|
| InChI | InChI=1S/C12H18NO2.ClHO4/c1-12(2)14-10-8-5-3-4-6-13(8)7-9(13)11(10)15-12;2-1(3,4)5/h3-4,8-11H,5-7H2,1-2H3;(H,2,3,4,5)/q+1;/p-1/t8-,9-,10-,11+,13?;/m0./s1 |
| InChIKey | RIGSMKUVUXRGEQ-ZMUITCRCSA-M |
| Mol Weight | 307.73 g/mol |
| Molecular Formula | C12H18ClNO6 |
| Exact Mass | 307.082265 g/mol |
| Parent InChIKey | SJEZRBXLYGWHMG-HTGOSZRMSA-M |
| Enantiomer InChIKey | RIGSMKUVUXRGEQ-YWPHUESCSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R,3R,9AS)-1,2-O-ISOPROPYLIDENE-3-METHYLSULFANYL-7,8-DIDEHYDRO-2H-QUINOLIZIDINE-1,2-DIOL
(3aR,6S,10aS,10bS)-2,2-Dimethyl-6-phenyl-3a,6,7,10,10a,10b-hexahydro-4H-[1,3]dioxolo[3,4]pyrrolo[1,2-a]azepine
(1R),2(S),8(S),8a(R)-8-Hydroxy-1,2-(isopropylidenedioxy)octahydro-5-indolizidinone
(3AR,4R,9AS,9BS)-4-(METHOXYMETHOXY)-2,2-DIMETHYLOCTAHYDRO-[1,3]-DIOXOLO-[4,5-G]-INDOLIZIDINE
(1R,6S,7S,8R,8aS)-1-hydroxy-6,7,8-tri(benzyloxy)indolizidine
(3AR,4S,6S,9AS,9BS)-4-[(TERT.-BUTYLDIMETHYLSILYLOXY)-METHYL]-2,2,-DIMETHYLOCTAHYDRO-[1,3]-DIOXOLO-[4,5-A]-INDOLIZIDINE
(3AR,4S,6S,9AS,9BS)-4-[(TERT.-BUTYLDIMETHYLSILYLOXY)-METHYL]-2,2,6-TRIMETHYLOCTAHYDRO-[1,3]-DIOXOLO-[4,5-A]-INDOLIZIDINE
(1S,2R,8R,8aR)-8-(Benzyloxy)-1,2-(isopropylidenedioxy)indolizine
5-exo,6-exo-Isopropylidenedioxy-2-methyl-2-azabicyclo[3.2.1]octan-3-one
(1R,2R,3R,5S,6R,7AR)-1,2-DIBENZYLOXY-3-(BENZYLOXYMETHYL)-6-HYDROXY-5-METHYLINDOLIZIDINE
| Title | Journal or Book | Year |
|---|---|---|
| A Short Route toward Chiral, Polyhydroxylated Indolizidines and Quinolizidines | The Journal of Organic Chemistry | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.